MA28224A1 - Nitro-oxyderives de medicaments contre l'hypertension. - Google Patents
Nitro-oxyderives de medicaments contre l'hypertension.Info
- Publication number
- MA28224A1 MA28224A1 MA29085A MA29085A MA28224A1 MA 28224 A1 MA28224 A1 MA 28224A1 MA 29085 A MA29085 A MA 29085A MA 29085 A MA29085 A MA 29085A MA 28224 A1 MA28224 A1 MA 28224A1
- Authority
- MA
- Morocco
- Prior art keywords
- nitro
- oxidine
- drugs against
- against hypertension
- hypertension
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
L'invention concerne des nitro-oxydérivés bêta-bloquants de formule générale (I) A-(Y-ONO2)s, y compris les énantiomères, diastéréoisomères et sels pharmaceutiquement acceptables correspondants, des compositions pharmaceutiques les renfermant, et leur utilisation pour le traitement de l'hypertension, des maladies cardio-vasculaires, du glaucome, de la migraine et des maladies vasculaires.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03104485 | 2003-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28224A1 true MA28224A1 (fr) | 2006-10-02 |
Family
ID=34639310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29085A MA28224A1 (fr) | 2003-12-02 | 2006-06-07 | Nitro-oxyderives de medicaments contre l'hypertension. |
Country Status (21)
Country | Link |
---|---|
US (1) | US20070060586A1 (fr) |
EP (1) | EP1748994B1 (fr) |
JP (1) | JP2007513113A (fr) |
KR (1) | KR20060120164A (fr) |
CN (1) | CN1906182A (fr) |
AP (1) | AP2006003622A0 (fr) |
AR (1) | AR047264A1 (fr) |
AT (1) | ATE423107T1 (fr) |
AU (1) | AU2004295105A1 (fr) |
BR (1) | BRPI0417182A (fr) |
CA (1) | CA2548127A1 (fr) |
DE (1) | DE602004019579D1 (fr) |
EA (1) | EA200600891A1 (fr) |
EC (1) | ECSP066590A (fr) |
ES (1) | ES2320002T3 (fr) |
IL (1) | IL176061A0 (fr) |
MA (1) | MA28224A1 (fr) |
NO (1) | NO20062527L (fr) |
TN (1) | TNSN06151A1 (fr) |
WO (1) | WO2005054218A1 (fr) |
ZA (1) | ZA200604463B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE437637T1 (de) | 2001-05-02 | 2009-08-15 | Nitromed Inc | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren |
EP1981852A1 (fr) * | 2006-02-06 | 2008-10-22 | NicOx S.A. | Dérivés d'apraclonidine et de brimodnidine comprenant des groupes nitrooxy comme agonistes des récepteurs alpha 2-adrénergiques |
WO2007090733A1 (fr) * | 2006-02-06 | 2007-08-16 | Nicox S.A. | Dérivés nitrooxy utilisables comme agonistes des récepteurs alpha 2 adrénergiques |
AU2021241591A1 (en) | 2020-03-24 | 2022-10-20 | Michael W. BURNET | Anti-infective and anti-viral compounds and compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3443998A1 (de) * | 1984-12-01 | 1986-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
ES2065291B1 (es) * | 1993-07-30 | 1995-10-01 | Prodesfarma Sa | "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente" |
IT1295694B1 (it) * | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
IT1311923B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
IT1314184B1 (it) * | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
-
2004
- 2004-12-01 EA EA200600891A patent/EA200600891A1/ru unknown
- 2004-12-01 AT AT04803433T patent/ATE423107T1/de not_active IP Right Cessation
- 2004-12-01 AU AU2004295105A patent/AU2004295105A1/en not_active Abandoned
- 2004-12-01 BR BRPI0417182-9A patent/BRPI0417182A/pt not_active IP Right Cessation
- 2004-12-01 EP EP04803433A patent/EP1748994B1/fr active Active
- 2004-12-01 AP AP2006003622A patent/AP2006003622A0/xx unknown
- 2004-12-01 CN CNA2004800409272A patent/CN1906182A/zh active Pending
- 2004-12-01 AR ARP040104486A patent/AR047264A1/es unknown
- 2004-12-01 CA CA002548127A patent/CA2548127A1/fr not_active Abandoned
- 2004-12-01 DE DE602004019579T patent/DE602004019579D1/de active Active
- 2004-12-01 WO PCT/EP2004/013682 patent/WO2005054218A1/fr active Application Filing
- 2004-12-01 US US10/581,450 patent/US20070060586A1/en not_active Abandoned
- 2004-12-01 KR KR1020067010381A patent/KR20060120164A/ko not_active Application Discontinuation
- 2004-12-01 ES ES04803433T patent/ES2320002T3/es active Active
- 2004-12-01 JP JP2006541891A patent/JP2007513113A/ja not_active Withdrawn
-
2006
- 2006-05-22 TN TNP2006000151A patent/TNSN06151A1/en unknown
- 2006-05-29 EC EC2006006590A patent/ECSP066590A/es unknown
- 2006-05-31 ZA ZA200604463A patent/ZA200604463B/en unknown
- 2006-05-31 IL IL176061A patent/IL176061A0/en unknown
- 2006-06-01 NO NO20062527A patent/NO20062527L/no not_active Application Discontinuation
- 2006-06-07 MA MA29085A patent/MA28224A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ATE423107T1 (de) | 2009-03-15 |
CN1906182A (zh) | 2007-01-31 |
NO20062527L (no) | 2006-06-30 |
ES2320002T3 (es) | 2009-05-18 |
EP1748994B1 (fr) | 2009-02-18 |
IL176061A0 (en) | 2006-10-05 |
TNSN06151A1 (en) | 2007-11-15 |
BRPI0417182A (pt) | 2007-03-06 |
WO2005054218A1 (fr) | 2005-06-16 |
US20070060586A1 (en) | 2007-03-15 |
EA200600891A1 (ru) | 2006-10-27 |
EP1748994A1 (fr) | 2007-02-07 |
ZA200604463B (en) | 2007-04-25 |
AP2006003622A0 (en) | 2006-06-30 |
KR20060120164A (ko) | 2006-11-24 |
CA2548127A1 (fr) | 2005-06-16 |
JP2007513113A (ja) | 2007-05-24 |
ECSP066590A (es) | 2006-10-17 |
DE602004019579D1 (de) | 2009-04-02 |
AU2004295105A1 (en) | 2005-06-16 |
AR047264A1 (es) | 2006-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN04246A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
US7183285B2 (en) | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | |
MA27801A1 (fr) | Nouveaux composes heterocycliques pour le traitement des affections inflammatoires et allergiques, leur procede de preparation et compositions pharmaceutiques les contenant | |
MX2008013836A (es) | Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos. | |
TNSN05165A1 (fr) | Derives de pyrrolopyrimidine | |
MXPA05010958A (es) | Derivados indazol como inhibidores jnk. | |
DK1689721T3 (da) | Aminopyrazolderivater som GSK-3-ihibitorer | |
TNSN08139A1 (fr) | Composes therapeutiques | |
GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
MA27316A1 (fr) | Derives d'indoline-phenylsulfonamide | |
MA27311A1 (fr) | Utilisation d'inhibiteurs de cetp et facultativement d'inhibiteurs de hmg-coa-reductase et/ou d'agents antihypertensifs | |
JP2005532372A5 (fr) | ||
NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
TNSN97044A1 (fr) | Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant. | |
KR20080064911A (ko) | 선택적 노르아드레날린 재흡수 억제제와 pdev 억제제의조합물 | |
ES2193875A1 (es) | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos. | |
SG151336A1 (en) | 1,3,4-oxadiazol-2-ones as ppar delta | |
MA27093A1 (fr) | Derives de sulfonamides, leur preparation et leur application comme medicaments. | |
TNSN07145A1 (fr) | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique | |
IL178167A0 (en) | 1,3,4-oxadiazol-2-ones as ppar delta modulators | |
TNSN00235A1 (fr) | Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant | |
NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
DK1641454T3 (da) | Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere | |
US7163945B2 (en) | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | |
US7199126B2 (en) | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |